Characterization of the transcriptional signature of C/EBPbeta isoforms (LAP/LIP) in Hep3B cells: Implication of LIP in pro-survival functions

Journal of Hepatology

Volumn 54, Issue 6, 2011, Pages 1185-1194

  Saint Auret, Gaëlle ^a,e   Danan, Jean Louis ^b,c   Hiron, Martine ^a   Blache, Céline ^a   Sulpice, Eric ^e   Tendil, Simon ^d   Daveau, Maryvonne ^a   Gidrol, Xavier ^d,e   Salier, Jean Philippe ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d DIF   (France)

^e CEA GRENOBLE   (France)

Author keywords

C EBPbeta isoforms; ChIP on chip; Hepatoma cell death; Target genes; Transcriptome

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; COMPLEMENTARY DNA; LIVER ENRICHED ACTIVATING PROTEIN; LIVER ENRICHED INHIBITORY PROTEIN; PACLITAXEL; STAUROSPORINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN HEP3B; CELL SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENETIC ENGINEERING; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; PROTEIN ISOFORMS; STAUROSPORINE; TRANSCRIPTION, GENETIC;

EID: 79956120774     PISSN: 01688278     EISSN: 01688278     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.09.021     Document Type: Article

References (51)

1. J. Lekstrom-Himes, and K.G. Xanthopoulos Biological role of the CCAAT/enhancer-binding protein family of transcription factors J Biol Chem 273 1998 28545 28548 (Pubitemid 28507532)
2. H. Schrem, J. Klempnauer, and J. Borlak Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation Pharmacol Rev 56 2004 291 330 (Pubitemid 38720832)
3. D.P. Ramji, and P. Foka CCAAT/enhancer-binding proteins: structure, function and regulation Biochem J 365 2002 561 575 (Pubitemid 34864439)
4. T. Sebastian, and P.F. Johnson Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta Cell Cycle 5 2006 953 957
5. S. Osada, H. Yamamoto, T. Nishihara, and M. Imagwa DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family J Biol Chem 271 1996 3891 3896 (Pubitemid 26065711)
6. E.A. Park, A.L. Gurney, S.E. Nizielski, P. Hakimi, Z. Cao, and A. Moorman Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) J Biol Chem 268 1993 613 619 (Pubitemid 23021366)
7. E.M. Eaton, and L. Sealy Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3 J Biol Chem 278 2003 33416 33421 (Pubitemid 37055795)
8. C. Trautwein, P. van der Geer, M. Karin, T. Hunter, and M. Chojkier Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA recognition elements J Clin Invest 93 1994 2554 2561 (Pubitemid 24177171)
9. P. Descombes, and U. Schibler A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA Cell 67 1991 569 579 (Pubitemid 121001471)
10. T. Luedde, M. Duderstadt, K.L. Streetz, F. Tacke, S. Kubicka, and M.P. Manns C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver Hepatology 40 2004 356 365 (Pubitemid 39062853)
11. P. Ruminy, C. Gangneux, S. Claeyssens, M. Scotte, M. Daveau, and J.P. Salier Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes Inflamm Res 50 2001 383 390 (Pubitemid 32777664)
12. A.L. Welm, S.L. Mackey, L.T. Timchenko, G.J. Darlington, and N.A. Timchenko Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein alpha mRNA J Biol Chem 275 2000 27406 27413
13. C. Coulouarn, C. Derambure, G. Lefebvre, R. Daveau, M. Hiron, and M. Scotte Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition J Hepatol 42 2005 860 869 (Pubitemid 40693203)
14. C. Coulouarn, G. Lefebvre, R. Daveau, F. Letellier, M. Hiron, and L. Drouot Genome-wide response of the human Hep3B hepatoma cell to proinflammatory cytokines, from transcription to translation Hepatology 42 2005 946 955 (Pubitemid 41401133)
15. A.M. Kvingedal Characterization of the 5′ region of the Atlantic salmon (Salmo salar) transferrin-encoding gene Gene 150 1994 335 339
16. Y. Supriatna, T. Kishimoto, M. Furuya, N. Tochigi, H. Ishiguro, and D. Tosh Expression of liver-enriched nuclear factors and their isoforms in alpha-fetoprotein-producing gastric carcinoma cells Exp Mol Pathol 82 2007 316 321 (Pubitemid 46686654)
17. M. Buck, H. Turner, and M. Chojkier LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation EMBO J 13 1994 851 860 (Pubitemid 24057516)
18. C.A. Belmokhtar, J. Hillion, and E. Segal-Bendirdjian Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms Oncogene 20 2001 3354 3362 (Pubitemid 32588984)
19. A. Stepczynska, K. Lauber, I.H. Engels, O. Janssen, D. Kabelitz, and S. Wesselborg Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation Oncogene 20 2001 1193 1202 (Pubitemid 32226245)
20. J.M. Schroeder-Gloeckler, S.M. Rahman, R.C. Janssen, L. Qiao, J. Shao, and M. Roper CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice J Biol Chem 282 2007 15717 15729 (Pubitemid 47093283)
21. D. Orellana, X. Liu, G.L. Wang, J. Jin, P. Iakova, and N.A. Timchenko Calmodulin controls liver proliferation via interactions with C/EBPbeta-LAP and C/EBPbeta-LIP J Biol Chem 285 2010 23444 23456
22. O. Meir, E. Dvash, A. Werman, and M. Rubinstein C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models PLoS One 5 2010 e9516
23. F. Siu, C. Chen, C. Zhong, and M.S. Kilberg CCAAT/enhancer-binding protein-beta is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene J Biol Chem 276 2001 48100 48107
24. I. Mendizabal, G. Rios, J.M. Mulet, R. Serrano, and I.F. de Larrinoa Yeast putative transcription factors involved in salt tolerance FEBS Lett 425 1998 323 328 (Pubitemid 28178915)
25. S. Liu, C. Croniger, C. Arizmendi, M. Harada-Shiba, J. Ren, and V. Poli Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene J Clin Invest 103 1999 207 213 (Pubitemid 29053138)
26. C.M. Croniger, C. Millward, J. Yang, Y. Kawai, I.J. Arinze, and S. Liu Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta have an attenuated response to cAMP and impaired carbohydrate metabolism J Biol Chem 276 2001 629 638 (Pubitemid 32050359)
27. C. Arizmendi, S. Liu, C. Croniger, V. Poli, and J.E. Friedman The transcription factor CCAAT/enhancer-binding protein β regulates gluconeogenesis and phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes J Biol Chem 274 1999 13033 13040
28. M. Prod'homme, I. Rieu, M. Balage, D. Dardevet, and J. Grizard Insulin and amino acids both strongly participate to the regulation of protein metabolism Curr Opin Clin Nutr Metab Care 7 2004 71 77 (Pubitemid 40348186)
29. C.G. Proud Regulation of protein synthesis by insulin Biochem Soc Trans 34 2006 213 216
30. C.A. Zahnow CCAAT/enhancer binding proteins in normal mammary development and breast cancer Breast Cancer Res 4 2002 113 121 (Pubitemid 34520736)
31. K. Sundfeldt, K. Ivarsson, M. Carlsson, S. Enerbäck, P.O. Janson, and M. Brännström The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression Br J Cancer 79 1999 1240 1248 (Pubitemid 29087905)
32. K. Rask, M. Thörn, F. Pontén, W. Kraaz, K. Sundfeldt, and L. Hedin Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer Int J Cancer 86 2000 337 343 (Pubitemid 30187493)
33. M. Oya, A. Horiguchi, R. Mizuno, K. Marumo, and M. Murai Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma Clin Cancer Res 9 2003 1021 1027 (Pubitemid 36323706)
34. E. Sterneck, S. Zhu, A. Ramirez, J.L. Jorcano, and R.C. Smart Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis Oncogene 25 2006 1272 1276
35. L. Sun, B.B. Fu, and D.G. Liu Systemic delivery of full-length C/EBP beta/liposome complex suppresses growth of human colon cancer in nude mice Cell Res 15 2005 770 776 (Pubitemid 41653914)
36. S. Zhu, K. Yoon, E. Sterneck, P.F. Johnson, and R.C. Smart CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling Proc Natl Acad Sci USA 99 2002 207 212 (Pubitemid 34060342)
37. P.L. Jones, D. Ping, and J.M. Boss Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB Mol Cell Biol 17 1997 6970 6981 (Pubitemid 27505927)
38. D. Mukherjee, K.H. Kaestner, K.K. Kovalovich, and L.E. Greenbaum Fas-induced apoptosis in mouse hepatocytes is dependent on C/EBPbeta Hepatology 33 2001 1166 1172 (Pubitemid 32378216)
39. C.F. Calkhoven, C. Muller, and A. Leutz Translational control of C/EBPalpha and C/EBPbeta isoform expression Genes Dev 14 2000 1920 1932 (Pubitemid 30639525)
40. C.A. Zahnow, P. Younes, R. Laucirica, and J.M. Rosen Overexpression of C/EBPβ-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer J Natl Cancer Inst 89 1997 1887 1891 (Pubitemid 28009825)
41. C.A. Zahnow, R.D. Cardiff, R. Laucirica, D. Medina, and J.M. Rosen A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation Cancer Res 61 2001 261 269 (Pubitemid 32095726)
42. M.H. Kim, and J. Fields Translationally regulated C/EBP beta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells Prostate 68 2008 1362 1371
43. B. Raught, A.C. Gingras, A. James, D. Medina, N. Sonenberg, and J.M. Rosen Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells Cancer Res 56 1996 4382 4386 (Pubitemid 26330444)
44. V.T. Solovyan, and J. Keski-Oja Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells J Cell Physiol 207 2006 445 453
45. R.R. Gomis, C. Alarcon, C. Nadal, C. Van Poznak, and J. Massague C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells Cancer cell 10 2006 203 214 (Pubitemid 44311064)
46. R.C. Chambers, P. Leoni, N. Kaminski, G.J. Laurent, and R.A. Heller Global expression profiling of fibroblast responses to transforming growth factor beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching Am J Pathol 162 2003 533 546 (Pubitemid 36267860)
47. T. Chen, J. Turner, S. McCarthy, S. Bettuzzi, and T.J. Yeatman Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent Cancer Res 64 2004 7412 7419 (Pubitemid 39372082)
48. K.B. Lee, J.H. Jeon, I. Choi, O.Y. Kwon, K. Yu, and K.H. You Clusterin, a novel modulator of TGF-beta signaling, is involved in Smad2/3 stability BBRC 366 2008 905 909
49. E. Frise, J.A. Knoblich, S. Younger-Shepherd, L.Y. Jan, and Y.N. Jan The Drosophila Numb protein inhibits signaling of the Notch receptor during cell-cell interaction in sensory organ lineage Proc Natl Acad Sci 93 1996 11925 11932 (Pubitemid 26347225)
50. S. Masuda, K. Kumano, K. Shimizu, Y. Imai, M. Kurokawa, and S. Ogawa Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300 Cancer Sci 96 2005 274 282 (Pubitemid 40895075)
51. D. Guo, J. Ye, L. Li, J. Dai, D. Ma, and C. Ji Down-regulation of Notch-1 increases co-cultured Jurkat cell sensitivity to chemotherapy Leuk Lymphoma 50 2009 270 278